| 1 | 2cureX AB (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 2 | 2Seventy Bio Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 3 | 3-D Matrix Ltd (Japan) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 7/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 4 | 4Basebio PLC (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 5 | 4D Molecular Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 6 | 4Sc AG (Germany) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 7 | 89bio Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 8 | A Science AB (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 9 | Aardvark Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 10 | AB Science SA (France) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 11 | Abcam Ltd (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 12 | AbCellera Biologics Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 13 | Abera Bioscience AB (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 14 | Abion Inc (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 15 | Abionyx Pharma SA (France) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 16 | Abivax SA (France) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 17 | ABL Bio Inc (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 18 | Abliva AB (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 19 | Absci Corp (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 20 | Acepodia Inc (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 21 | Achilles Therapeutics PLC (ADR) (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 22 | Aclaris Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 23 | Acrivon Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 24 | Acticor Biotech SA (France) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 25 | Actinium Pharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 26 | Actinogen Medical Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 27 | Active Biotech AB publ (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 28 | Actuate Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 29 | Acumen Pharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 30 | Acurx Pharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 31 | Adagene Inc (ADR) (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 32 | Adagio Medical Holdings Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 33 | Adalta Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 34 | Adaptive Biotechnologies Corp (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 35 | ADC Therapeutics SA (Switzerland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 36 | Adial Pharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 37 | Adicet Bio Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 38 | Aditxt Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 39 | Adocia SA (France) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 40 | Advagene Biopharma Co Ltd (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 41 | Advanced Medical Equipment SA (Poland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 42 | Adverum Biotechnologies Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 43 | Aeon Biopharma Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 44 | Affimed NV (Germany) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 45 | AFYREN SA (France) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 46 | Agalawatte Plantations PLC (Sri Lanka) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 47 | Agile Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 48 | Agios Pharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 49 | AgResearch Ltd (New Zealand) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 50 | Airway Medix SA (Poland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 51 | Akari Therapeutics PLC (ADR) (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 52 | Akero Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 53 | Akeso Inc (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 54 | Aldeyra Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 55 | Alector Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 56 | Algernon Health Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 5/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 57 | Algorae Pharmaceuticals Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 58 | Aligos Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 59 | Allakos Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 60 | Allarity Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 61 | Alligator Bioscience AB (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 62 | Allogene Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 63 | Alpha Cognition Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 64 | Alpha IVF Group Bhd (Malaysia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 8/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 65 | Alpha Tau Medical Ltd (Israel) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 66 | Altamira Therapeutics Ltd (Bermuda) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 67 | Alterola Biotech Inc (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 68 | Alvotech SA (Luxembourg) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 69 | Alzamend Neuro Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 7/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 70 | AlzeCure Pharma AB (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 71 | Alzinova AB (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 72 | Amplia Therapeutics Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 73 | AN2 Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 74 | AnaptysBio Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 75 | Anatolia TaniveBytklj Unli Ar Ge SiveTiA (Turkey) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 76 | Anavex Life Sciences Corp (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 77 | Anebulo Pharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 78 | AnGes Inc (Japan) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 79 | Angion Biomedica Corp (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 80 | Anhui Wanbang Pharmacutcl Tchnlgy Co Ltd (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 81 | Annovis Bio Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 82 | Anteotech Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 83 | Anthem BioSciences Ltd (India) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 84 | Anti-Microbial Savior BioteQ Co Ltd (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 85 | Anya Biopharm Inc (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 86 | AP Biosciences Inc (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 87 | Apimeds Pharmaceuticals US Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 88 | Apogee Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 89 | Applied BioCode Corp (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 90 | Applied Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 91 | Aprea Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 92 | AptaBio Therapeutics Inc (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 93 | Aptamer Sciences Inc (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 94 | Aptorum Group Ltd (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 95 | Arbutus Biopharma Corp (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 96 | Arcellx Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 97 | Arch Biopartners Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 98 | Arcturus Therapeutics Holdings Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 99 | Arcutis Biotherapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 100 | Ardelyx Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 101 | Argenica Therapeutics Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 102 | Argent BioPharma Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 103 | argenx SE (Netherlands) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 104 | Arovella Therapeutics Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 105 | Arrivent Biopharma Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 106 | Arrowhead Pharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 107 | ARS Pharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 108 | Artelo Biosciences Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 109 | Arterra Bioscience SpA (Italy) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 110 | Artiva Biotherapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 111 | Ascelia Pharma AB (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 112 | Ascendis Pharma A/S (ADR) (Denmark) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 113 | Ascentage Pharma Group International (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 114 | Asep Medical Holdings Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 115 | Aspire Biopharma Holdings Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 116 | Astria Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 117 | ATAI Life Sciences NV (Netherlands) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 118 | Atara Biotherapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 119 | Atea Pharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 120 | Athira Pharma Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 121 | Aton SA (France) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 122 | Atreca Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 123 | aTyr Pharma Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 124 | Aura Biosciences Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 125 | Avacta Group Plc (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 126 | Avalo Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 127 | Avantium NV (Netherlands) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 128 | Avecho Biotechnology Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 129 | Avenue Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 130 | Avicanna Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 131 | Axcella Health Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 132 | Axonics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 133 | Axsome Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 134 | Azitra Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 135 | BACHEM HOLDING AG (Switzerland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 136 | Bactiquant A/S (Denmark) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 137 | Barinthus Biotherapeutics PLC - ADR (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 138 | Basilea Pharmaceutica AG Allschwil (Switzerland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 139 | Battelle Memorial Institute (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 140 | BB BIOTECH AG (Switzerland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 141 | Beam Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 142 | BeBetter Med Inc (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 143 | Beijing Northland Biotech Co Ltd (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 144 | Beijing Sun-Novo Pharma Research Co Ltd (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 145 | Belite Bio Inc (ADR) (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 146 | Benitec Biopharma Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 147 | BeOne Medicines AG (Switzerland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 148 | Bergenbio ASA (Norway) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 149 | Beyondspring Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 150 | BGI Genomics Co Ltd (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 151 | Bicycle Therapeutics PLC (ADR) (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 152 | Bide Pharmatech Co Ltd (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 153 | Bio Meat Foodtech LP (Israel) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 154 | Bio Path Holdings Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 155 | Bio-Works Technologies AB (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 156 | BioArctic AB (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 157 | Biodexa Pharmaceuticals PLC-ADR (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 158 | Bioextrax AB publ (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 159 | Biogend Therapeutics Co Ltd (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 160 | BioInfra Life Science Inc (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 161 | BioInvent International AB (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 162 | BioLASCO Taiwan Co Ltd (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 163 | BioLine RX Ltd (Israel) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 164 | BioMark Diagnostics Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 165 | Biomea Fusion Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 166 | Biomind Labs Inc (Uruguay) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 167 | Biomm SA (Brazil) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 168 | Biomx Inc (Israel) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 169 | Bioneer Corp (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 170 | BioNexus Gene Lab Corp (Malaysia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 171 | BioNTech SE - ADR (Germany) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 172 | Biophytis SA (France) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 173 | Bioqual Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 5/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 174 | BioRestorative Therapies Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 175 | Biosergen AB (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 176 | BIOTON SA (Poland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 177 | Biotron Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 178 | Biovaxys Technology Corp (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 7/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 179 | Bioventix PLC (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 180 | BioVersys AG (Switzerland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 181 | Biovica International AB (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 7/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 182 | BioXcel Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 183 | bioXXmed AG (Germany) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 184 | Bioxyne Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 185 | Bivictrix Therapeutics PLC (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 186 | Black Diamond Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 187 | bluebird bio Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 188 | Bonus Biogroup Ltd (Israel) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 189 | Boundless Bio Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 190 | BPH Energy Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 191 | BPH Global Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 192 | BRAIN Biotech AG (Germany) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 193 | Briacell Therapeutics Corp (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 7/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 194 | BridgeBio Oncology Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 195 | Bright Minds Biosciences Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 196 | BrightPath Biotherapeutics Co Ltd (Japan) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 197 | Brii Biosciences Ltd (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 198 | BRIM Biotechnology Inc (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 199 | BTB Korea Co Ltd (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 200 | BTC Health Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 201 | C4 Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 202 | Cabaletta Bio Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 203 | Cadrenal Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 204 | Calcimedica Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 205 | CAMP4 Therapeutics Corp (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 206 | CanBas Co Ltd (Parent) (Japan) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 207 | Candel Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 208 | Cannabix Technologies Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 7/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 209 | Cantargia AB (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 210 | Captor Therapeutics SA (Poland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 211 | Carbios SA (France) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 212 | Carbiotix AB (publ) (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 213 | Cardio Diagnostics Holdings Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 214 | Cardiol Therapeutics Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 215 | CARGO Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 216 | Caribou Biosciences Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 217 | Carisma Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 218 | Carna Biosciences, Inc. (Japan) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 219 | Cartesian Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 220 | Cavendish Hydrogen ASA (Norway) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 221 | CDT Equity Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 222 | Celcuity Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 223 | Cell Source Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 224 | Cellectis SA (France) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 225 | Cellivery Therapeutics Inc (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 226 | CellSeed Inc (Japan) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 227 | Celyad Oncology SA (Belgium) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 228 | Centessa Pharmaceuticals PLC - ADR (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 229 | Century Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 230 | CervoMed Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 231 | CG Oncology Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 232 | Charles River Lbrtrs ntrntl Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/28/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 233 | Charles River Nederland B.V. (Netherlands) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | Statement | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 234 | Check Cap Ltd (Israel) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 235 | Checkpoint Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 236 | Chemomab Therapeutics Ltd - ADR (Israel) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 237 | ChemPartner PharmaTech Co Ltd (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 238 | Chimerix Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 239 | China Health Group Inc (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 240 | Chiome Bioscience Inc (Japan) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 241 | Chitogenx Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 10/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 242 | Chordia Therapeutics Inc (Japan) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 8/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 243 | Cibus Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 244 | Cidara Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 245 | Circio Holding ASA (Norway) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 246 | Citius Oncology Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 247 | Cizzle Biotechnology Holdings PLC (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 248 | Clarity Pharmaceuticals Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 249 | Clearmind Medicine Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 7/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 250 | Clearside Biomedical Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 251 | Clene Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 252 | Clever Culture Systems Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 253 | Climb Bio Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 254 | Clinuvel Pharmaceuticals Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 255 | Cloudbreak Pharma Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 256 | CNS Pharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 257 | Codexis Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 258 | Cogent Biosciences Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 259 | Cognition Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 260 | Cogstate Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 261 | Collplant Biotechnologies Ltd (Israel) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 262 | Collplant Biotechnologies Ltd - ADR (Israel) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 263 | Compass Pathways PLC (ADR) (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 264 | Compass Therapeutics Inc. (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 265 | Connect Biopharma Holdings Ltd (ADR) (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 266 | Context Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 267 | Corestemchemon Inc (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 268 | Corvus Pharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 269 | Coya Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 270 | Creative Medical Technology Holdings Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 271 | Crescent Biopharma Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 272 | Crinetics Pharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 273 | Crispr Therapeutics AG (Switzerland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 274 | Cronex Co Ltd (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 275 | CTC Centro de Tecnologia Canavieira SA (Brazil) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 276 | Cullinan Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 277 | Curable Inc (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 278 | Curacle Co Ltd (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 279 | Curasight A/S (Denmark) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 280 | CureVac BV (Germany) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 281 | Curocell Inc (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 282 | Cybin Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 283 | Cyclerion Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 284 | Cyfuse Biomedical KK (Japan) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 285 | Cynata Therapeutics Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 286 | Cyteir Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 287 | Cytogen Inc (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 288 | D.Western Therapeutics Institute Inc (Japan) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 289 | Defence Therapeutics Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 290 | Denali Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 291 | Dermata Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 292 | Deutsche Biotech Innovativ AG (Germany) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 293 | Dextech Medical AB (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 294 | Diagonal Bio AB (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 295 | DiaMedica Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 296 | Diamyd Medical AB (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 8/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 297 | Dianthus Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 298 | Dicot Pharma AB (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 299 | Dimerix Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 300 | DNA Chip Research Inc (Japan) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 301 | DNA Group TR Ltd (Israel) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 302 | DND Pharmatech Inc (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 303 | Dogwood Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 304 | DreamCIS Inc (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 305 | DV Biomed Co Ltd (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 306 | Dyadic International Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 307 | Dyne Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 308 | e-Therapeutics plc (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 1/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 309 | Eagle Filters Group Oyj (Finland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 310 | Ecopro HN Co Ltd (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 311 | Edesa Biotech Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 312 | Edgewise Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 313 | Editas Medicine Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 314 | EGF Theramed Health Corp (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 315 | Eledon Pharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 316 | Elevation Oncology Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 317 | Emyria Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 318 | ENCell Co Ltd (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 319 | ENDRA Life Sciences Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 320 | Energenesis Biomedical Co Ltd (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 321 | enGene Holdings Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 7/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 322 | Engineering Research and Consulting, Inc. (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | Statement | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 323 | Enimmune Corp (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 324 | Enliven Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 325 | Enlivex Therapeutics Ltd (Israel) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 326 | Ensysce Biosciences Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 327 | Entera Bio Ltd (Israel) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 328 | Entheon Biomedical Corp (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 8/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 329 | Environmental Clean Technologies Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 330 | Eone Diagnomics Genome Center Co Ltd (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 331 | Epi Biotech Co Ltd (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 332 | Equillium Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 333 | Erasca Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 334 | Eurofins Scientific SE (Luxembourg) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 335 | Eurofins-Cerep SA (France) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 336 | European Institute of Science AB (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 337 | Evaxion A/S (ADR) (Denmark) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 338 | Everfront Biotech Holding Co Ltd (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 339 | Evogene Ltd (Israel) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 340 | Evolus Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 341 | EvoNext Holdings Ltd (Switzerland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 342 | Exact Sciences Corp (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 343 | Exact Therapeutics AS (Norway) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 344 | Exelixis Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 7/4/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 345 | Exicure Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 346 | eXoZymes Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 347 | Faraday Future Intelligent Electric Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 348 | Faron Pharmaceuticals Oy (Finland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 349 | Femtobiomed Inc (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 350 | FendX Technologies Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 351 | Fermentalg SA (France) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 352 | Fibrobiologics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 353 | FibroGen Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 354 | Finch Therapeutics Group Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 355 | Fluicell AB (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 356 | Fluoguide AS (Denmark) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 357 | Foresee Pharmaceuticals Co Ltd (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 358 | Formycon AG (Germany) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 359 | Forte Biosciences Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 360 | Fortrea Holdings Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 361 | Fractyl Health Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 362 | Frontage Holdings Corp (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 363 | Fulcrum Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 364 | Fullhope Biomedical Co Ltd (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 365 | FunPep Co Ltd (Japan) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 366 | Fusion Antibodies PLC (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 367 | Futura Medical PLC (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 368 | G1 Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 369 | G2GBio Inc (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 370 | Gain Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 371 | Galapagos NV (Belgium) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 372 | Galecto Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 373 | Galera Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 374 | Galmed Pharmaceuticals Ltd (Israel) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 375 | GemPharmatech Co Ltd (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 376 | Genelux Corp (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 377 | Genematrix Inc (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 378 | Genenta Science SPA (ADR) (Italy) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 379 | Generation Bio Co (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 380 | Genetic Analysis AS (Norway) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 381 | Genexine Inc (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 382 | GenFleet Therapeutics (Shanghai) Inc (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 383 | Genflow Biosciences PLC (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 384 | Genmab A/S (Denmark) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 385 | Genome&Company Inc (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 386 | GENOMED SA (Poland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 387 | Genomics Bioscience & Technology Co Ltd (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 388 | Genomictree Inc (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 389 | Genomtec SA (Poland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 390 | Genor Biopharma Holdings Ltd (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 391 | genOway SA (France) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 392 | Genprex Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 393 | Genscript Biotech Corp (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 394 | Gensight Biologics SA (France) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 395 | Genus plc (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 396 | Genxone SA (Poland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 397 | Geovax Labs Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 398 | Gevo Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 399 | GFC Green Fields Capital Ltd (Israel) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 400 | GH Research PLC (Ireland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 401 | GI Innovation Inc (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 402 | Ginkgo Bioworks Holdings Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 403 | GL Pharm Tech Corp (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 404 | Global Bioenergies SA (France) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 405 | GlycoNex Inc (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 406 | Glycorex Transplantation AB (publ) (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 407 | GNI Group Ltd (Japan) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 408 | GNT Biotech & Medicals Corp (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 409 | GO-DX Corporation (Aust) Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 410 | Golden Biotechnology Corp. (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 411 | Goldenwell Biotech Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 412 | Gongwin Biopharm Holdings Co Ltd (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 413 | Gossamer Bio Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 414 | Grace Therapeutics, Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 415 | GRAIL Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 416 | Greenlight Biosciences Holdings PBC (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 417 | Greenwich Lifesciences Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 418 | GRI Bio Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 419 | Gubra A/S (Denmark) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 420 | Hamlet BioPharma AB (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 421 | HanchorBio Inc (Cayman Islands) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 422 | Hangzhou Bio-sncrty Phrm-tch Co Ltd (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 423 | Hangzhou Tigermed Consulting Co Ltd (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 424 | Hansa Biopharma AB (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 425 | Harvard Apparatus Regenertv Tchnlgy Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 426 | HBL Hadasit Bio Holdings Ltd (Israel) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 427 | Hcw Biologics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 428 | Healios KK (Japan) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 429 | Heartseed Inc (Japan) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 7/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 430 | Heidelberg Pharma AG (Germany) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 8/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 431 | Helix Biopharma Corp (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 4/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 432 | HEM Pharma Inc (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 433 | Hemogenyx Pharmaceuticals PLC (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 434 | Hemostemix Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 435 | Hepion Pharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 436 | Herantis Pharma Oyj (Finland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 437 | Hexima Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 438 | Hi-Great Group Holding Co (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 439 | HighTide Therapeutics Inc (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 440 | Hillevax Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 441 | HitGen Inc (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 442 | HLB Pep Co Ltd (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 443 | HLB Science Inc (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 444 | Holista Colltech Limited (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 445 | Hua Medicine (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 446 | Human Metabolome Technologies Inc (Japan) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 447 | hVIVO PLC (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 448 | Hyenergy SA (Poland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 449 | Hyundai ADM Bio lnc (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 450 | Ibio Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 451 | ICON PLC (Ireland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 452 | IDL Diagnostics AB (publ) (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 453 | IDT Australia Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 454 | IGC Pharma Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 455 | ImageneBio Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 456 | Imagion Biosystems Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 457 | Imgt Corp Ltd (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 458 | Immatics NV (Germany) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 459 | Immix Biopharma Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 460 | Immuneering Corp (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 461 | ImmuneOncia Therapeutics Inc (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 462 | Immunic Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 463 | Immunitybio Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 464 | Immunotech Biopharm Ltd (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 465 | Immunovant Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 466 | Immunovia AB (publ) (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 467 | ImmuPharma PLC (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 468 | Immutep Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 469 | Imugene Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 470 | IN8bio Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 471 | Inalways Corp (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 472 | Incyte Corp (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 473 | Indaptus Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 474 | Inflarx NV (Germany) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 475 | Inhalerx Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 476 | Inhibikase Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 477 | Inhibitor Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 478 | Inhibrx Biosciences Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 479 | Initiator Pharma A/S (Denmark) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 480 | INmune Bio Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 481 | Innovotech Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 482 | Inotiv Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 483 | Inozyme Pharma Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 484 | Instil Bio Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 485 | Institute of Gas Technology (d/b/a GTI Energy Corporation) (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 486 | Intech Biopharm Ltd (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 487 | IntegraGen SA (France) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 488 | Intellia Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 489 | Intelligene Inc (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 490 | Intensity Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 491 | Intocell Inc (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 492 | Invap SE (Argentina) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 493 | Inventionmed SA (Poland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 494 | InventisBio Co Ltd (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 495 | Inventiva SA (France) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 496 | Invex Therapeutics Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 497 | Invion Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 498 | IO Biotech Inc (Denmark) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 499 | Iovance Biotherapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 500 | IPI Legacy Liquidation Co (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 501 | Iqvia Holdings Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 502 | IQVIA RDS Inc. (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | Statement | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 503 | Island Pharmaceuticals Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 504 | ispace Inc (Japan) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 505 | iTeos Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 506 | Iterum Therapeutics PLC (Ireland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 507 | IXICO plc (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 508 | Jacobio Pharmaceuticals Group Co Ltd (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 509 | Jade Biosciences Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 510 | Janux Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 511 | Jasper Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 512 | Jeevan Scientific Technology Ltd (India) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 513 | Jiangsu Yahong Meditech Co Ltd (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 514 | Joinn Laboratories China Co Ltd (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 515 | Jounce Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2022 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 516 | JS Link Inc (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 517 | Jupiter Neurosciences Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 518 | JW (Cayman) Therapeutics Co Ltd (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 519 | Jyong Biotech Ltd (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 520 | Kadimastem Ltd (Israel) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 521 | Kainos Medicine Inc (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 522 | Kairos Pharma Ltd (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 523 | KALA BIO Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 524 | Kalaris Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 525 | Kalvista Pharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 7/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 526 | Kang Stem Biotech Co Ltd (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 527 | KBR Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 7/4/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 528 | Keros Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 529 | Kezar Life Sciences Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 530 | Kidswell Bio Corp (Japan) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 531 | Kineta Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 532 | Kintor Pharmaceutical Ltd (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 533 | Kiora Pharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 534 | Kiromic Biopharma Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 535 | Klaria Pharma Holding AB (publ) (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 536 | Kodiak Sciences Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 537 | Kolon TissueGene Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 538 | Korro Bio Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 539 | Kringle Pharma Inc (Japan) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 540 | Kronos Bio Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 541 | Kuros Biosciences AG (Switzerland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 542 | Kuvatris Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 543 | Kymera Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 544 | Kyverna Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 545 | Laekna Inc (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 546 | Lantern Pharma Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 547 | Larimar Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 548 | Larkberget AB (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 549 | LAVA Therapeutics NV (Netherlands) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 550 | Leap Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 551 | Legend Biotech Corp (ADR) (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 552 | Lenz Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 553 | Lexeo Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 554 | Lidds AB (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 555 | LigaChem Biosciences Inc (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 556 | Light AI Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 557 | Liminatus Pharma Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 558 | Linical Co Ltd (Japan) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 559 | Lipella Pharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 560 | Lipocine Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 561 | Lipum AB (publ) (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 562 | Liquidia Corp (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 563 | Lisata Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 564 | Locus Cell Co Ltd (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 565 | Longboard Pharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 566 | Longeveron Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 567 | Longevity Health Holdings Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 568 | LTR Pharma Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 569 | LTT Bio-Pharma Co Ltd (Japan) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 570 | Lumosa Therapeutics Co Ltd (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 571 | Lunai Bioworks Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 572 | LungLife AI Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 573 | Lyell Immunopharma Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 574 | Lyra Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 575 | Lytix Biopharma AS (Norway) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 576 | Maat Pharma SA (France) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 577 | Mabion SA (Poland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 578 | Macrogen Inc (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 579 | MacroGenics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 580 | Madrigal Pharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 581 | Maia Biotechnology Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 582 | Many Bright Ideas Technologies Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 583 | Marinus Pharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 584 | Matinas BioPharma Holdings Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 585 | Matricelf Ltd (Israel) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 586 | Mavens Biotech Ltd (India) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 587 | Maze Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 588 | MBX Biosciences Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 589 | MDxHealth SA - ADR (Belgium) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 590 | Medesis Pharma SA (France) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 591 | Medicenna Therapeutics Corp (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 592 | Medicofarma Biotech SA (Poland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 593 | Medicure Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 594 | Medigen Biotechnology Corp (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 595 | MediGene AG (Germany) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 596 | Medipost Co Ltd (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 597 | Medivir AB (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 598 | Medizen Humancare Inc (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 599 | Medlab Clinical Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 600 | Medpace Holdings Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 601 | Medpacto Inc (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 602 | MEDRx Co Ltd (Japan) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 603 | Megapro Biomedical Co Ltd (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 604 | Mendus AB (publ) (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 605 | Mersana Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 606 | Merus NV (Netherlands) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 607 | MetaVia Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 608 | Metsera Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 609 | Microbix Biosystems Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 610 | Microwave Chemical Co Ltd (Japan) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 611 | Milestone Pharmaceuticals Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 612 | Millennium Food-Tech LP (Israel) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 613 | Mind Medicine (MindMed) Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 614 | MindBio Therapeutics Corp (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 615 | Mineralys Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 616 | Mink Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 617 | Mira Pharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 618 | MiRXES Holding Co Ltd (Singapore) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 619 | Modalis Therapeutics Corp (Japan) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 620 | Modus Therapeutics Holding AB (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 621 | Molecular Partners AG (Switzerland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 622 | Moleculin Biotech Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 623 | Molecure SA (Poland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 624 | Monopar Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 625 | Monte Rosa Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 626 | Moogene Medi Co Ltd (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 627 | Moolec Science SA (Luxembourg) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 628 | Morphic Holding Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 629 | MorphoSys AG (Germany) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 630 | Movano Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 631 | Mural Oncology PLC (Ireland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 632 | Mustang Bio Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 633 | Mycotopia Therapies Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 634 | Mydecine Innovations Group Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 635 | N4 Pharma PLC (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 636 | Nanjing Leads Biolabs Co Ltd (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 637 | Nano Mrna Co Ltd (Japan) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 638 | Nanobiotix SA (France) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 639 | Nanogroup SA (Poland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 640 | Nanotech Indonesia Global Tbk PT (Indonesia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 641 | NanoViricides Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 642 | Nascent Biotech Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 643 | National Research Corp (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 644 | NatureCell Co Ltd (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 645 | Nautilus Biotechnology Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 646 | Neoimmunetech Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 647 | Neonc Technologies Holdings Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 648 | Neovacs SA (France) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 649 | Neumora Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 650 | Neuphoria Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 651 | Neuphoria Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 652 | Neural Therapeutics Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 4/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 653 | Neurogene Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 654 | Neuroscientific Biopharmaceuticals Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 655 | Neurosense Therapeutics Ltd (Israel) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 656 | Neurotech International Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 657 | Neurothera Labs Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 7/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 658 | Newron Pharmaceuticals SpA (Italy) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 659 | Neximmune Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 660 | Nextage Therapeutics Ltd (Israel) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 661 | NextCell Pharma AB (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 5/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 662 | NextCure Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 663 | Nfl Biosciences SAS (France) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 664 | NGM Biopharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 665 | Nightingale Health Oyj (Finland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 666 | Nirvana Life Sciences Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 7/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 667 | NKMax Co Ltd (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 668 | NLS Pharmaceutics AG (Switzerland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 669 | Noile-Immune Biotech Inc (Japan) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 670 | Norda ASA (Norway) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 671 | Northwest Biotherapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 672 | Notable Labs Ltd (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 673 | NOUL Co Ltd (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 674 | Novelstem International Corp (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 675 | Novomics Co Ltd (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 676 | Noxopharm Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 677 | NRX Pharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 678 | NuCana PLC (ADR) (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 679 | Numeral Ltd (Mauritius) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 8/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 680 | Numinus Wellness Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 5/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 681 | Nurexone Biologic Inc (Israel) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 682 | Nuvalent Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 683 | Nuvation Bio Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 684 | Nuvectis Pharma Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 685 | Nykode Therapeutics ASA (Norway) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 686 | Nyrada Inc (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 687 | OBI Pharma Inc (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 688 | Oculis Holding AG (Switzerland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 689 | OKYO Pharma Ltd (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 690 | Olema Pharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 691 | OliX Pharmaceuticals Inc (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 692 | OmniAB Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 693 | OncoCross Co Ltd (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 694 | Oncoinvent ASA (Norway) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 695 | Oncolys Biopharma Inc (Japan) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 696 | Onconic Therapeutics Inc (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 697 | OncoTherapy Science, Inc. (Japan) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 698 | Onemednet Corp (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 699 | Onesource Specialty Pharma Ltd (India) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 700 | Onkure Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 701 | Opsy Holding AB (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 702 | Opthea Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 703 | OptiBiotix Health PLC (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 704 | Organoidsciences Ltd (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 705 | ORIC Pharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 706 | Origin Agritech Ltd. (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 707 | Orum Therapeutics Inc (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 708 | Oryzon Genomics SA (Spain) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 709 | OS Therapies Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 710 | Ose Immunotherapeutics SA (France) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 711 | OSR Holdings Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 712 | Outlook Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 713 | Ovid Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 714 | Ovoca Bio PLC (Ireland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 715 | Oxford BioMedica plc (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 716 | Oxurion NV (Belgium) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 717 | P3 Health Partners Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 718 | Pacific Edge Ltd (New Zealand) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 719 | Palisade Bio Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 720 | Pangaea Oncology SA (Spain) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 721 | PanGen Biotech Inc (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 722 | Paradigm Biopharmaceuticals Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 723 | Pasithea Therapeutics Corp (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 724 | Passage Bio Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 725 | Patrys Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 726 | PCI Biotech Holding ASA (Norway) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 727 | PDS Biotechnology Corp (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 728 | Peak Bio Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 729 | Pell Bio Med Technology Co Ltd (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 730 | PepGen Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 731 | Peptidream Inc (Japan) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 732 | Peptonic Medical AB (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 733 | Percheron Therapeutics Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 734 | Personalis Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 735 | Pharma Mar SA (Spain) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 736 | PharmAbcine Inc (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 737 | Pharmadax Inc (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 738 | PharmaEngine Inc (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 739 | PharmaResearch Bio Co Ltd (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 740 | PharmaResources Shanghai Co Ltd (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 741 | Pharmigene Inc (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 742 | Pharvaris NV (Netherlands) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 743 | Phathom Pharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 744 | Philogen SpA (Italy) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 745 | Phio Pharmaceuticals Corp (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 746 | PhoenixBio Co Ltd (Japan) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 747 | Phytohealth Corp (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 748 | Plant Advanced Technologies PAT SA (France) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 749 | Plantarc Bio Ltd (Israel) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 750 | Polaris Group LLC (Cayman Islands) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 751 | Poltreg SA (Poland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 752 | Polyrizon Ltd (Israel) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 753 | Pond Technologies Holdings Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 754 | Poolbeg Pharma PLC (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 755 | Poseida Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 756 | Poxel SA (France) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 757 | PRA Health Sciences Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | Statement | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 758 | Praxis Precision Medicines Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 759 | Precision BioSciences Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 760 | Predilife SA (France) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 761 | Prelude Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 762 | Prestige Biopharma Ltd (Singapore) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 763 | Prime Medicine Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 764 | PRISM BioLab Co Ltd (Japan) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 765 | Processa Pharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 766 | ProKidney Corp (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 767 | Promimic AB (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 768 | Promis Neurosciences Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 769 | ProQR Therapeutics NV (Netherlands) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 770 | Protagonist Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 771 | Protara Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 772 | Proteina Co Ltd (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 773 | Proteomics International LaboratoriesLtd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 774 | Psomagen Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 775 | Psyence Group Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 776 | Pulmatrix Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 777 | Pure Biologics SA (Poland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 778 | Puretech Health PLC (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 779 | PYC Therapeutics Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 780 | Qrons Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 781 | Qualigen Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 782 | Quantum BioPharma Ltd (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 783 | Quantum Genomics SA (France) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 784 | Quest PharmaTech Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 7/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 785 | Quince Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 786 | Quoin Pharmaceuticals Ltd - ADR (Israel) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 787 | Qyuns Therapeutics Co Ltd (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 788 | Race Oncology Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 789 | Rafael Holdings Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 4/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 790 | Rain Enhancement Technologies Holdco Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 791 | Rain Oncology Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 792 | Rakovina Therapeutics Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 793 | Rallybio Corp (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 794 | Rani Therapeutics Holdings Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 795 | Raphael Pharmaceutical Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 796 | Rapport Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 797 | Rapt Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 798 | RaQualia Pharma Inc (Japan) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 799 | Read Gene SA (Poland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 800 | Recursion Pharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 801 | Redx Pharma PLC (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 802 | Regencell Bioscience Holdings Ltd (Hong Kong) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 803 | Regenxbio Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 804 | Regulus Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 805 | Rein Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 806 | RELIEF THERAPEUTICS Holding SA (Switzerland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 807 | Relmada Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 808 | RenovoRx Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 809 | Repare Therapeutics Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 810 | Replimune Group Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 811 | Restart Life Sciences Corp (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 812 | Resverlogix Corp (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 813 | RetinalGenix Technologies Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 814 | Revelation Biosciences Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 815 | Reviva Pharmaceuticals Holdings Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 816 | Revive Therapeutics Ltd (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 817 | Revolution Medicines Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 818 | Ribomic Inc (Japan) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 819 | Rocket Pharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 820 | Roivant Sciences Ltd (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 821 | Rokit Healthcare Inc (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 822 | Rubicon Research Ltd (India) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 823 | Ryvu Therapeutics SA (Poland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 824 | SAB Biotherapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 825 | Sailong Pharmaceutical Group Co Ltd (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 826 | Sana Biotechnology Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 827 | SanBio Co Ltd (Japan) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 7/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 828 | Saniona AB (Denmark) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 829 | Sareum Holdings Plc (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 830 | Satellos Bioscience Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 831 | Scancell Holdings Plc (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 4/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 832 | Scholar Rock Holding Corp (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 833 | Scinai Immunotherapeutics Ltd - ADR (Israel) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 834 | SCM LifeScience Co Ltd (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 835 | Sds Optic SA (Poland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 836 | Selvita SA (Poland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 837 | Senhwa Biosciences Inc (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 838 | Sensei Biotherapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 839 | Sensorion SA (France) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 840 | Senti Biosciences Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 841 | SenzaGen AB (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 842 | Seoulin Bioscience Co Ltd (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 843 | Sepura Ltd (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 844 | Seres Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 845 | Sernova Biotherapeutics Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 7/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 846 | Serodus AS (Norway) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 847 | Shanghai Aladdin Biochemical Tech Co Ltd (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 848 | Shanghai Medicilon Inc (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 849 | Shanxi Jinbo Bio-pharmaceutical Co Ltd (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 850 | Shaperon Inc (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 851 | Sharp Therapeutics Corp (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 852 | Shattuck Labs Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 853 | Shin Nippon Biomedical Laboratories Ltd (Japan) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 854 | Shine-On BioMedical Co Ltd (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 855 | Shortwave Life Sciences PLC (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 10/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 856 | Shouyao Holdings Co Ltd (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 857 | Shree Ganesh Remedies Ltd (India) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 858 | Shuttle Pharmaceuticals Holdings Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 859 | Sichuan Kelun-Biotech Biophrmctcl Co Ltd (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 860 | Silence Therapeutics plc (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 861 | Silexion Therapeutics Corp (Israel) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 862 | SillaJen Inc (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 863 | SINEW Pharma Inc (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 864 | Sino Biological Inc (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 865 | Sinocelltech Group Ltd (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 866 | Sionna Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 867 | Sirona Biochem Corp (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 7/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 868 | Skinbiotherapeutics PLC (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 869 | Skye Bioscience Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 870 | Sofiva Genomics Co Ltd (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 871 | Sol Gel Technologies Ltd (Israel) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 872 | Solar Foods Oyj (Finland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 873 | Solarvest Bioenergy Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 4/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 874 | Soleno Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 875 | Sona Nanotech Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 7/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 876 | Sonnet Biotherapeutics Holdings Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 877 | Spago Nanomedical AB (publ) (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 878 | Spero Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 879 | Spirit Scientific Co Ltd (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 880 | SpringWorks Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 881 | Sprint Bioscience AB (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 882 | Spruce Biosciences Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 883 | Spyre Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 884 | SS Innovations International Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 885 | StageZero Life Sciences Ltd (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 886 | Starpharma Holdings Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 887 | Stayble Therapeutics AB (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 888 | Steakholder Foods Ltd (Israel) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 889 | Stem Cells Spin SA (Poland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 890 | StemCyte International Ltd (Cayman Islands) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 891 | Steminent Biotherapeutics Inc (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 892 | StimCell Enegetics Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 8/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 893 | Stoke Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 894 | Storage Drop Storage Technologies Ltd (Israel) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 895 | Strategic Partners A/S (Denmark) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 896 | Structure Therapeutics Inc (ADR) (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 897 | Sun Pharma Advanced Research Co Ltd (India) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 898 | Sunhawk Vision Biotech Inc (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 899 | Sunho Biologics Inc (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 900 | Sunmax Biotechnology Co Ltd (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 901 | Suven Life Sciences Ltd (India) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 902 | Sygnis SA (Poland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 903 | Synairgen plc (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 904 | Syndax Pharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 905 | Syneos Health Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 906 | SyneuRx International Taiwan Corp (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 907 | Syngene International Ltd (India) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 908 | Synlogic Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 909 | Syntara Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 910 | SyntheticMR AB (publ) (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 911 | Syros Pharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 912 | TaiGen Biopharmaceuticals Holdings Ltd (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 913 | TaiMed Biologics Inc (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 914 | TaiRx Inc (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 915 | Taiwan Bio Therapeutics Co Ltd (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 916 | TaiwanJ Pharmaceuticals Co Ltd (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 917 | Takara Bio Inc (Japan) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 918 | Take Solutions Ltd (India) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 919 | Talis Biomedical Corp (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 920 | Talisker Resources Ltd (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 921 | Tango Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 922 | Tanvex Biopharma Inc (Cayman Islands) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 923 | Taysha Gene Therapies Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 924 | TC Biopharm (Holdings) PLC - ADR (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 925 | Tectonic Therapeutic Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 926 | Telix Pharmaceuticals Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 927 | Telo Genomics Corp (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 928 | Tempest Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 929 | Tenax Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 930 | Tenaya Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 931 | Terns Pharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 932 | Terragen Holdings Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 933 | Tetratherix Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 934 | TFF Pharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 935 | Tharimmune Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 936 | TheraCryf PLC (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 937 | Theranexus SA (France) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 938 | Therapeutic Solutions International Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 939 | Therma Bright Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 4/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 940 | Thiogenesis Therapeutics Corp (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 941 | Thor Medical ASA (Norway) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 942 | TiumBio Co Ltd (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 943 | Tiziana Life Sciences Ltd (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 944 | Tiziana Life Sciences Ltd - ADR (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 945 | TME Pharma NV (Germany) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 946 | TMS Co Ltd (Japan) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 8/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 947 | Toleranzia AB (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 948 | Tonix Pharmaceuticals Holding Corp (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 949 | ToolGen Inc (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 950 | Tourmaline Bio Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 951 | TRACON Pharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 952 | Transcode Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 953 | Transgene Biotek Ltd (India) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 954 | TransThera Sciences (Nanjing) Inc (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 955 | Traws Pharma Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 956 | Trevena Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 957 | Trevi Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 958 | Tryptamine Therapeutics Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 959 | Tsubota Laboratory Inc (Japan) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 960 | TuHURA Biosciences Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 961 | Tvardi Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 962 | Twi Biotechnology Inc (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 963 | TYK Medicines Inc (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 964 | Tyra Biosciences Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 965 | Ulisse Biomed Spa (Italy) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 966 | Unicocell Biomed Co Ltd (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 967 | Unicycive Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 968 | Uniqure NV (Netherlands) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 969 | Unity Biotechnology Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 970 | Urogen Pharma Ltd (Israel) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 971 | Urteste SA (Poland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 972 | Vaccinex Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 973 | Valbiotis SA (France) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 974 | ValiRx Plc (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 975 | Vanta Bioscience Ltd (India) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 976 | Vaxcyte Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 977 | Vaxil Bio Ltd (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 978 | Vectus Biosystems Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 979 | Verastem Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 980 | Veritas In Silico Inc (Japan) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 981 | Veru Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 982 | Verve Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 983 | Vicarious Surgical Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 984 | ViGenCell Inc (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 985 | Vigil Neuroscience Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 986 | Viking Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 987 | Vimta Labs Ltd (India) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 988 | Vir Biotechnology Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 989 | ViroGates A/S (Denmark) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 990 | Virpax Pharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 991 | Visen Pharmaceuticals (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 992 | Vistagen Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 993 | VIVA Biotech Holdings (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 994 | Vivakor inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 995 | Vivo Bio Tech Ltd (India) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 996 | Vivoryon Therapeutics NV (Germany) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 997 | VolitionRX Ltd (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 998 | Vor Biopharma Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 999 | Voyager Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 1,000 | vTv Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 1,001 | Vyne Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 1,002 | Vyome Holdings Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 1,003 | Vytrus Biotech SA (Spain) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 1,004 | Wave Life Sciences Ltd (Singapore) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 1,005 | Waverley Pharma Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 1,006 | Welgene Biotech Co Ltd (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 1,007 | Wilk Technologies Ltd (Israel) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 1,008 | WuXi AppTec Co Ltd (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 1,009 | X T L Biopharmaceuticals Ltd (ADR) (Israel) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 1,010 | XBiotech Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 1,011 | Xbrane Biopharma AB (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 1,012 | Xencor Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 1,013 | Xenon Pharmaceuticals Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 1,014 | Xilio Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 1,015 | Xinjiang Bai Hua Cun Pharma Tech Co Ltd (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 1,016 | Xintela AB (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 1,017 | XSpray Pharma AB (publ) (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 1,018 | XtalPi Holdings Ltd (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 1,019 | Y Biologics Inc (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 1,020 | YD Bio Ltd (Taiwan, Republic of China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 1,021 | Yield10 Bioscience Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 1,022 | Yubo International Biotech Ltd (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 1,023 | Zealand Pharma A/S (Denmark) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 1,024 | Zelira Therapeutics Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 1,025 | Zenas Biopharma Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 1,026 | Zentalis Pharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 1,027 | Zentek Ltd (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 1,028 | Zevra Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 1,029 | Zura Bio Ltd (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 1,030 | Zymeworks Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 1,031 | ZYUS Life Sciences Corp (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2025 | News | SEC | Bankruptcy | Suits | Liens |